Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

Postoperative surveillance for non-small cell lung cancer resected with curative intent: developing a patient-centered approach.

Mollberg NM, Ferguson MK.

Ann Thorac Surg. 2013 Mar;95(3):1112-21. doi: 10.1016/j.athoracsur.2012.09.075. Epub 2013 Jan 23. Review.

PMID:
23352418
2.

Does postoperative serum interleukin-6 influence early recurrence after curative pulmonary resection of lung cancer?

Kita H, Shiraishi Y, Watanabe K, Suda K, Ohtsuka K, Koshiishi Y, Goya T.

Ann Thorac Cardiovasc Surg. 2011;17(5):454-60. Epub 2011 Jul 13.

3.

[Postoperative follow-up and surveillance for NSCLC patients].

Nakagawa K, Ohde Y, Okumura T, Kondo H.

Gan To Kagaku Ryoho. 2009 Sep;36(9):1419-22. Japanese.

PMID:
19755810
4.

Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.

Kumar P, Herndon J 2nd, Langer M, Kohman LJ, Elias AD, Kass FC, Eaton WL, Seagren SL, Green MR, Sugarbaker DJ.

Cancer. 1996 Jun 1;77(11):2393-9.

5.

Results of long-term follow-up of patients with completely resected non-small cell lung cancer.

Endo C, Sakurada A, Notsuda H, Noda M, Hoshikawa Y, Okada Y, Kondo T.

Ann Thorac Surg. 2012 Apr;93(4):1061-8. doi: 10.1016/j.athoracsur.2012.01.004. Epub 2012 Mar 3.

PMID:
22386090
6.

Relevance of an intensive postoperative follow-up after surgery for non-small cell lung cancer.

Westeel V, Choma D, Clément F, Woronoff-Lemsi MC, Pugin JF, Dubiez A, Depierre A.

Ann Thorac Surg. 2000 Oct;70(4):1185-90.

PMID:
11081867
7.

Frequency of local recurrence following segmentectomy of stage IA non-small cell lung cancer is influenced by segment localisation and width of resection margins--implications for patient selection for segmentectomy.

Sienel W, Stremmel C, Kirschbaum A, Hinterberger L, Stoelben E, Hasse J, Passlick B.

Eur J Cardiothorac Surg. 2007 Mar;31(3):522-7; discussion 527-8. Epub 2007 Jan 16.

PMID:
17229574
8.

Serum protein expression predicts recurrence in patients with early-stage lung cancer after resection.

D'Amico TA, Brooks KR, Joshi MB, Conlon D, Herndon J 2nd, Petersen RP, Harpole DH Jr.

Ann Thorac Surg. 2006 Jun;81(6):1982-7; discussion 1987.

PMID:
16731117
9.

Factors associated with local and distant recurrence and survival in patients with resected nonsmall cell lung cancer.

Varlotto JM, Recht A, Flickinger JC, Medford-Davis LN, Dyer AM, Decamp MM.

Cancer. 2009 Mar 1;115(5):1059-69. doi: 10.1002/cncr.24133.

10.

Completely resected N1 non-small cell lung cancer: factors affecting recurrence and long-term survival.

Fujimoto T, Cassivi SD, Yang P, Barnes SA, Nichols FC, Deschamps C, Allen MS, Pairolero PC.

J Thorac Cardiovasc Surg. 2006 Sep;132(3):499-506. Epub 2006 Jul 28.

11.

[Study on local recurrence in patients undergoing curative surgical resection of lung cancer].

Yusa T, Momiki S, Fujino M, Sekine Y, Aoyagi T, Kimura H, Fujisawa T, Yamaguchi Y.

Nihon Kyobu Geka Gakkai Zasshi. 1992 Nov;40(11):1973-7. Japanese.

PMID:
1336788
12.

Stage I nonsmall cell lung cancer. A multivariate analysis of treatment methods and patterns of recurrence.

Harpole DH Jr, Herndon JE 2nd, Young WG Jr, Wolfe WG, Sabiston DC Jr.

Cancer. 1995 Sep 1;76(5):787-96.

13.

Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer.

Sonett JR, Suntharalingam M, Edelman MJ, Patel AB, Gamliel Z, Doyle A, Hausner P, Krasna M.

Ann Thorac Surg. 2004 Oct;78(4):1200-5; discussion 1206. Review.

PMID:
15464470
14.

Clinical controlled comparison between lobectomy and segmental resection for patients over 70 years of age with clinical stage I non-small cell lung cancer.

Cheng YD, Duan CJ, Dong S, Zhang H, Zhang SK, Wang SQ, Zhang CF.

Eur J Surg Oncol. 2012 Dec;38(12):1149-55. doi: 10.1016/j.ejso.2012.08.001. Epub 2012 Aug 15.

PMID:
22901959
15.

Adjuvant chemotherapy for surgically resected non-small cell lung cancer.

Heon S, Johnson BE.

J Thorac Cardiovasc Surg. 2012 Sep;144(3):S39-42. doi: 10.1016/j.jtcvs.2012.03.039. Epub 2012 Apr 13. Review.

16.

The present status of surgery for lung cancer.

Lacquet LK.

Acta Chir Belg. 1996 Nov-Dec;96(6):245-51. Review.

PMID:
9008764
17.

Safety-net burden hospitals and likelihood of curative-intent surgery for non-small cell lung cancer.

Virgo KS, Little AG, Fedewa SA, Chen AY, Flanders WD, Ward EM.

J Am Coll Surg. 2011 Nov;213(5):633-43. doi: 10.1016/j.jamcollsurg.2011.07.014. Epub 2011 Sep 8.

PMID:
21907598
18.

Positron emission tomography-computed tomography for postoperative surveillance in non-small cell lung cancer.

Choi SH, Kim YT, Kim SK, Kang KW, Goo JM, Kang CH, Kim JH.

Ann Thorac Surg. 2011 Nov;92(5):1826-32; discussion 1832. doi: 10.1016/j.athoracsur.2011.07.005. Epub 2011 Oct 31.

PMID:
22051278
19.

Follow-up and surveillance of the lung cancer patient following curative-intent therapy.

Colice GL, Rubins J, Unger M; American College of Chest Physicians.

Chest. 2003 Jan;123(1 Suppl):272S-283S. Review.

PMID:
12527585
20.

Modality of failure following resection of stage I and stage II non-small cell lung cancer.

Ramacciato G, Paolini A, Volpino P, Aurello P, Balesh AM, D'Andrea N, Del Grande E, Passaro U, Tosato F, Fegiz G.

Int Surg. 1995 Apr-Jun;80(2):156-61.

PMID:
8530234

Supplemental Content

Support Center